Buying the fear? Check out top stock ideas of best performing PMS funds of May

Time of India

2 days ago

While the Iran-Israel conflict may have made stock market outlook wobbly in the near term, all past dips eventually get bought into, creating crisis opportunities for long-term investors. Top performing
PMS
fund managers have made sizable bets on stocks like
Precision Camshafts
,
Hitachi Energy India
, and
Nuvama Wealth Management
as geopolitical fears create entry points in quality names.
'Any correction coming would be an opportunity,' said Vikas Khemani of Carnelian Asset Management. 'India's earnings growth this year will be very robust, thanks to RBI easing, low inflation, and credit growth. I don't see a major risk, though the short term is hard to call.'
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Live Comfortably: 60 m² Prefab Bungalow for Seniors in Sidi Bel Abbes
Pre Fabricated Homes | Search Ads
Search Now
Undo
Leading the pack is NAFA Asset Managers' Clean Tech Portfolio, which returned a stellar 16.01% in May, the highest among PMS peers. The fund is riding hard on industrial and energy transition plays — with Precision Camshafts (18.37%), Hitachi Energy India (18.03%), and Linde India (11.82%) commanding hefty allocations. This portfolio is essentially a powertrain of cleantech conviction, according to data sourced from PMS Bazaar.
Negen Capital's Special Situations & Technology Fund, up 15.35%, isn't far behind. Its top holdings include Camlin Fine Sciences, Nuvama Wealth, and HEG Ltd, reflecting a tilt toward platform plays and special situation beneficiaries. Interestingly, Nuvama Wealth Management — a capital markets business — features in three top-performing PMS portfolios this month.
'We have a significant allocation to the capital markets story — AMCs, brokerages, exchanges,' said Siddharth Vora of PL Asset Management. 'It's a structural story, but we are not structural participants. We'll stay as long as the quantitative triggers remain.'
Live Events
One of the month's more repeated names is Interarch Building Products, showing up in four portfolios — including Accelt, Bonanza, Waya, and Anand Rathi. It's a quiet favourite among PMS managers riding the infra and pre-engineered buildings theme.
Among small-cap plays, Nine Rivers Capital's Aurum Small Cap Opportunities delivered a solid 14.4%, thanks to high-conviction allocations to Intellect Design Arena (9.6%), Astra Microwave, and CCL Products — the latter also held by Ambit Investment's Emerging Giants portfolio.
Another PMS manager with twin strategies in the top 10 — Samvitti Capital — is doubling down on mid-cap manufacturers and pharma exporters, including Kaynes Technology, Force Motors, Strides Pharma, and Gokaldas Exports, all of which appear in both its Aggressive Growth and Active Alpha portfolios.
Blue Jet Healthcare, a relatively new pharma listing, has found favour with both Accelt and Waya, while Camlin Fine Sciences, TD Power Systems, and Shankara Building Products show up in PMS strategies with more than 13% monthly returns.
'We expect markets to pause after the ~10% Nifty rally,' said Seshadri Sen of
Emkay Global
. 'Valuations are stretched, and if Middle East tensions escalate, a sell-off is possible. But we remain positive on discretionary, tech, and materials for the medium term.'
Despite the nerves, fund managers remain anchored in India's structural story — and they're placing their bets accordingly. From precision auto parts and building solutions to electronics, pharma, and financial services, this month's PMS portfolios offer a snapshot of what smart money believes will ride out the global storm.
Morgan Stanley noted in its recent India strategy that this is likely to be a 'stock pickers' market,' adding: 'We are capitalization agnostic.'
With that in mind, for investors looking to buy the fear, these stocks might just be your roadmap.
Also Read |
Rs 1 lakh gold, $78 oil, 1,300 point Sensex crash: Israel's Friday the 13th bombshell
(
Disclaimer
: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)